Connor, Clark & Lunn Investment Management (CC&L)’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,207
| Closed | -$1.25M | – | 1508 |
|
|
2025
Q1 | $1.25M | Buy |
+36,207
| New | +$1.25M | 0.01% | 877 |
|
|
2024
Q4 | – | Sell |
-12,148
| Closed | -$309K | – | 1413 |
|
|
2024
Q3 | $309K | Buy |
+12,148
| New | +$309K | ﹤0.01% | 1229 |
|
|
2022
Q4 | – | Sell |
-50,158
| Closed | -$499K | – | 1207 |
|
|
2022
Q3 | $499K | Buy |
50,158
+33,309
| +198% | +$331K | ﹤0.01% | 820 |
|
|
2022
Q2 | $153K | Sell |
16,849
-351,105
| -95% | -$3.19M | ﹤0.01% | 956 |
|
|
2022
Q1 | $3.74M | Buy |
+367,954
| New | +$3.74M | 0.02% | 377 |
|